KARA SHIEH: Open Payments
NPI 1124767306 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 55 payments from 20 companies in 2025. Trend: 2023 $1,314 · 2024 $962 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $154 |
| Amgen Inc. | 5 | $85 |
| Novo Nordisk Inc | 4 | $76 |
| Lilly USA, LLC | 4 | $74 |
| PROTEGA PHARMACEUTIALS INC | 1 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Tactile Systems Technology Inc | 1 | $48 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Astellas Pharma US Inc | 1 | $31 |
Products named: QULIPTA, KRYSTEXXA, ROXYBOND, MOUNJARO, Kerendia, TRELEGY ELLIPTA, Flexitouch Plus, Wegovy.
Industry payments across AZ — which companies pay providers there.
